Disposition of oligonucleotides in isolated perfused rat kidney: Involvement of scavenger receptors in their renal uptake

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 1, 1996, Pages 284-290

  Sawai, Kenzo ^a   Mahato, Ram I ^a   Oka, Yoshikazu ^a   Takakura, Yoshinobu ^a   Hashida, Mitsuru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 ACETAMIDO 4' ISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; ANTISENSE OLIGONUCLEOTIDE; BOVINE SERUM ALBUMIN; DEXTRAN SULFATE; INULIN; PHOSPHOROTHIOIC ACID DERIVATIVE; POLYCYTIDYLIC ACID; RECEPTOR; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DRUG DISPOSITION; INTRAARTERIAL DRUG ADMINISTRATION; ISOLATED KIDNEY; KIDNEY TUBULE ABSORPTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; URINARY EXCRETION; VEIN BLOOD FLOW;

ANIMALS; KIDNEY; MALE; MEMBRANE PROTEINS; OLIGONUCLEOTIDES; PERFUSION; PROTEIN BINDING; RATS; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER; SCAVENGER RECEPTORS, CLASS B;

EID: 0030440928     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. AGRAWAL, S., TEMSAMANI, J. AND TANG, J. A.: Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proc. Natl. Acad. Sci. U.S.A. 88: 7595-7599, 1991.
2. BAYEVER, E., IVERSEN, P., SMITH, L., SPINOLO, J. AND ZON, G.: Systemic human antisense therapy begins. Antisense Res. Dev. 2: 109-110, 1992.
3. BENNETT, C. F., CONDON, T. P., GRIMM, S., CHAN, H. AND CHIANG, M.-Y.: Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides. J. Immunol. 152: 3530-3540, 1994.
4. BOADO, R. J., KANO, Y.-S., WU, D. AND PARDRIDGE, W. M.: Rapid plasma clearance and metabolism in vivo of a phosphorothioate oligodeoxynucleotide with a single, internal phosphodiester bond. Drug Metab. Dispos. 23: 1297-1300, 1995.
5. BROWN, D. A., KANG, S.-H., GRYAZNOV, S. M., DEDIONISIO, L., HEIDENREICH, O., SULLIVAN, S., XU, X. AND NERENBERG, M. I.: Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding. J. Biol. Chem. 269: 26801-26805, 1994.
6. BURGESS, T. L., FISHER, E. F., ROSS, S. L., BREADY, J. V., QIAN, Y.-X., BAYEWITCH, L. A., COHEN, A. M., HERRERA, C. J., HU, S. S.-F., KRAMER, T. B., LOTT, F. D., MARTIN, F. H., PIERCE, G. F., SIMONET, L. AND FARRELL, C. L.: The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc. Natl. Acad. Sci. U.S.A. 92: 4051-4055, 1995.
7. COMPER, W. D. AND GLASGOW, E. F.: Charge selectivity in kidney ultrafiltration. Kidney Int. 47: 1242-1251, 1995.
8. 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats. J. Pharmacol. Exp. Ther. 267: 1181-1190, 1993.
9. CROOKE, S. T.: Oligonucleotides as potential therapeutic agents. In Trends and Future Perspectives in Peptide and Protein Drug Delivery, ed. by V. H. L. Lee, M. Hashida and Y. Mizushima, pp. 297-320, Harwood Academic Publishers, Chur, Switzerland, 1995.
10. DEAN, N. M. AND MCKAY, R.: Inhibition of protein kinase C-α-expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proc. Natl. Acad. Sci. U.S.A. 9: 11762-11766, 1994.
11. EPSTEIN, F. H., BROSNAN, J. T., TANGE, J. D. AND ROSS, B. D.: Improved function with amino acids in the isolated perfused rat kidney. Am. J. Physiol. 243: F284-F292, 1982.
12. GALBRAITH, W. M., HOBSON, W. C., GICLAS, P. C., SCHECHTER, P. J. AND AGRAWAL, S.: Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey. Antisense Res. Dev. 4: 201-206, 1994.
13. GANONG, W. F.: Review of Medical Physiology, 15th ed., p. 649, Appleton & Lange, Norwalk, CT, 1991.
14. GHOSH, M. K. AND COHEN, J. S.: Oligodeoxynucleotides as antisense inhibitors of gene expression. Prog. Nucleic Acid Res. Mol. Biol. 42: 79-126, 1992.
15. GHOSH, M. K., GHOSH, K. AND COHEN, J. S.: Phosphorothioate- phosphorodiester oligonucleotide co-polymers: Assessment for antisense application. Anticancer Drug Design 8: 15-32, 1993.
16. HALL, S. AND ROWLAND, M.: Influence of fraction unbound upon the renal clearance of furosemide in the isolated perfused rat kidney. J. Pharmacol. Exp. Ther. 232: 263-268, 1985.
17. IVERSEN, P. L., MATA, J., TRACEWELL, W. G. AND ZON, G.: Pharmacokinetics of an antisense phosphorothioate oligodeoxynucleotide against rev from human immunodeficiency virus type 1 in the adult male rat following single injection and continuous infusion. Antisense Res. Dev. 4: 43-52, 1994.
18. KAKUTANI, T., YAMAOKA, K., HASHIDA, M. AND SEZAKI, H.: A new method for assessment of drug disposition in muscle: Application of statistical moment theory to local perfusion systems. J. Pharmacokinet. Biopharm. 13: 609-631, 1985.
19. KRIEGER, M., ACTON, S., ASKENAS, J., PEARSON, A., PENMAN, M. AND RESNICK, D.: Molecular flypaper, host defense, and atherosclerosis: Structure, binding properties and functions of macrophage scavenger receptors. J. Biol. Chem. 268: 4569-4572, 1993.
20. LEE, H. S. AND KOH, H. I.: Visualization of binding and uptake of oxidised low density lipoproteins by cultured mesangial cells. Lab. Invest. 71: 200-208, 1994.
21. MAACK, T.: Physiological evaluation of the isolated perfused kidney. Am. J. Physiol. 238: F71-F78, 1980.
22. MIHARA, K., HOJO, T., FUJIKAWA, M., TAKAKURA, Y., SEZAKI, H. AND HASHIDA, M.: Disposition characteristics of protein drugs in the perfused rat kidney. Pharm. Res. 10: 823-827, 1993.
23. MIYAO, T., TAKAKURA, Y., AKIYAMA, T., YONEDA, F., SEZAKI, H. AND HASHIDA, M.: Stability and pharmacokinetic characteristics of oligonucleotides modified at terminal linkages in mice. Antisense Res. Dev. 5: 115-121, 1995.
24. OBERBAUER, R., SCHREINER, G. F. AND MEYER, T. W.: Renal uptake of an 18-mer phophorothioate oligonucleotide. Kidney Int. 48: 1226-1232, 1995.
25. PEARSON, A. M., RICH, A. AND KRIEGER, M.: Polynucleotide binding to macrophage scavenger receptors depends on the formation of base-quartet-stabilized four-stranded helíces. J. Biol. Chem. 268: 3546-3554, 1993.
26. PEREZ, J. R., LI, Y., STEIN, C. A., MAJUMDER, S., VAN-OORSCHOT, A. AND NARAYANAN, R.: Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides. Proc. Natl. Acad. Sci. U.S.A. 91: 5957-5961, 1994.
27. RAPPAPORT, J., HANSS, B., KOPP, J. B., COPELAND, T. D., BRUGGEMAN, L. A., COFFMAN, T. M. AND KLOTMAN, P. E.: Transport of phosphorothioate oligonucleotides in kidney: Implications for molecular therapy. Kidney Int. 47: 1462-1469, 1995.
28. SAIJO, Y., PERLAKY, L., WANG, H. AND BUSCH, H.: Pharmacokinetics, tissue distribution, and stability of antisense oligonucleotide phosphorothioate ISIS 3466 in mice. Oncol. Res. 6: 243-249, 1994.
29. SAMBROOK, J., FRITSCH, E. F. AND MINIATIS, T.: Molecular Cloning: A Laboratory Mannual, 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1989.
30. 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate. Mol. Pharmacol. 45: 932-943, 1994.
31. SARMIENTO, U. M., PEREZ, J. R., BECKER, J. M. AND NARAYANAN, R.: In vivo toxicological effects of rel A antisense phosphorothioates in CD-1 mice. Antisense Res. Dev. 4: 99-107, 1994.
32. SAWAI, K., MIYAO, T., TAKAKUBA, Y. AND HASHIDA, M.: Renal disposition characteristics of oligonucleotides modified at terminal linkages in the perfused rat kidney. Antisense Res. Dev. 5: 279-287, 1995.
33. SCHLONDORFF, D.: The glomerular mesangial cell: An expanding role for a specialized pericyte. FASEB J. 1: 272-281, 1987.
34. STEIN, C. A. AND CHENG, Y.-C.: Antisense oligonucleotides as therapeutic agents: Is the bullet really magical? Science (Wash. DC) 261: 1004-1012, 1993.
35. TAYLOR, A. AND GRANGER, D. N.: Exchange of macromolecules across the microcirculation. In Handbook of Physiology, Section 2, The Cardiovascular System, ed. by E. M. Renkin and C. C. Michel, pp. 492-494, American Physiological Society, Bethesda, MD, 1984.
36. VYAS, S. V., PARKER, J.-A. AND COMPER, W. D.: Uptake of dextran sulfate by glomerular intracellular vesicles during kidney ultrafiltration. Kidney Int. 47: 945-950, 1995.
37. YAMAOKA, K, NAKAGAWA, T. AND UNO, T.: Statistical moments in pharmacokinetics. J. Pharmacokinet. Biopharm. 6: 547-558, 1978.
38. YAMAOKA, K., TANIGAWARA, Y., NAKAGAWA, T. AND UNO, T.: A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio-Dyn. 4: 879-885, 1981.
39. ZHANG, R., LU, Z., ZHAO, H., ZHANG, X., DIASIO, R. B., HABUS, I., JIANG, Z., IYER, R. P., YU, D. AND AGRAWAL, S.: In vivo stability, disposition and metabolism of a "hybrid" oligonucleotide phosphorothioate in rats. Biochem. Pharmacol. 54: 545-556, 1995.
40. ZHAO, Q., TEMSAMANI, J., IADAROLA, P. L., JIANG, Z. AND AGRAWAL, S.: Effect of different chemically modified oligodeoxynucleotides on immune stimulation. Biochem. Pharmacol. 51: 173-182, 1996.